# Kulicke & Soffa Industries Inc: financial statements, quarterly

KLIC · Nasdaq · CIK 56978 · [Technology](/sectors/technology.md) · fiscal year ends Oct 3

Pages: [Overview](/companies/klic.md) · [Financials](/companies/klic/financials.md) · [Filings](/companies/klic/filings.md) · [Insiders](/companies/klic/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/klic/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-10-04) | Q1 FY2026 (2026-01-03) | Q2 FY2026 (2026-04-04) | Q3 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [202 d](/filings/0000056978-25-000081.md) | [171](/filings/0000056978-25-000029.md) | [172](/filings/0000056978-25-000056.md) | [182](/filings/0000056978-25-000071.md) | [181 d](/filings/0000056978-25-000081.md) | [166](/filings/0000056978-26-000012.md) | [162](/filings/0000056978-26-000020.md) | [148](/filings/0000056978-26-000032.md) | [178 d](/filings/0000056978-25-000081.md) | [200](/filings/0000056978-26-000012.md) | [243](/filings/0000056978-26-000020.md) | [330](/filings/0000056978-26-000032.md) |
| Cost of revenue | $m | [106 d](/filings/0000056978-25-000081.md) | [91.3](/filings/0000056978-25-000029.md) | [156](/filings/0000056978-25-000056.md) | [96.9](/filings/0000056978-25-000071.md) | [93.7 d](/filings/0000056978-25-000081.md) | [79.0](/filings/0000056978-26-000012.md) | [122](/filings/0000056978-26-000020.md) | [79.2](/filings/0000056978-26-000032.md) | [96.3 d](/filings/0000056978-25-000081.md) | [101](/filings/0000056978-26-000012.md) | [123](/filings/0000056978-26-000020.md) | [172](/filings/0000056978-26-000032.md) |
| Gross profit | $m | [95.8 d](/filings/0000056978-25-000081.md) | [79.9](/filings/0000056978-25-000029.md) | [16.5](/filings/0000056978-25-000056.md) | [84.7](/filings/0000056978-25-000071.md) | [87.7 d](/filings/0000056978-25-000081.md) | [87.1](/filings/0000056978-26-000012.md) | [40.4](/filings/0000056978-26-000020.md) | [69.2](/filings/0000056978-26-000032.md) | [81.2 d](/filings/0000056978-25-000081.md) | [99.0](/filings/0000056978-26-000012.md) | [120](/filings/0000056978-26-000020.md) | [158](/filings/0000056978-26-000032.md) |
| Research and development | $m | [37.6 d](/filings/0000056978-25-000081.md) | [36.8](/filings/0000056978-25-000029.md) | [37.7](/filings/0000056978-25-000056.md) | [37.9](/filings/0000056978-25-000071.md) | [38.8 d](/filings/0000056978-25-000081.md) | [37.8](/filings/0000056978-26-000012.md) | [37.2](/filings/0000056978-26-000020.md) | [35.7](/filings/0000056978-26-000032.md) | [38.8 d](/filings/0000056978-25-000081.md) | [40.4](/filings/0000056978-26-000012.md) | [38.4](/filings/0000056978-26-000020.md) | [43.9](/filings/0000056978-26-000032.md) |
| Selling, general and administrative | $m | [38.7 d](/filings/0000056978-25-000081.md) | [41.4](/filings/0000056978-25-000029.md) | [39.5](/filings/0000056978-25-000056.md) | [38.5](/filings/0000056978-25-000071.md) | [46.2 d](/filings/0000056978-25-000081.md) | [38.6](/filings/0000056978-26-000012.md) | [48.0](/filings/0000056978-26-000020.md) | [39.6](/filings/0000056978-26-000032.md) | [41.5 d](/filings/0000056978-25-000081.md) | [40.8](/filings/0000056978-26-000012.md) | [42.7](/filings/0000056978-26-000020.md) | [45.8](/filings/0000056978-26-000032.md) |
| Operating income | $m | [19.5 d](/filings/0000056978-25-000081.md) | [1.7](/filings/0000056978-25-000029.md) | [(105)](/filings/0000056978-25-000056.md) | [8.3](/filings/0000056978-25-000071.md) | [2.7 d](/filings/0000056978-25-000081.md) | [86.6](/filings/0000056978-26-000012.md) | [(84.7)](/filings/0000056978-26-000020.md) | [(6.1)](/filings/0000056978-26-000032.md) | [0.9 d](/filings/0000056978-25-000081.md) | [17.8](/filings/0000056978-26-000012.md) | [38.6](/filings/0000056978-26-000020.md) | [68.3](/filings/0000056978-26-000032.md) |
| Interest expense | $m | [0.0 d](/filings/0000056978-23-000172.md) | [0.0](/filings/0000056978-24-000034.md) | [0.0](/filings/0000056978-24-000064.md) | [0.0](/filings/0000056978-25-000071.md) | [0.0 d](/filings/0000056978-25-000081.md) | [0.0](/filings/0000056978-26-000012.md) | [0.0](/filings/0000056978-26-000020.md) | [0.0](/filings/0000056978-26-000032.md) | [0.0 d](/filings/0000056978-25-000081.md) | [0.0](/filings/0000056978-26-000012.md) | [0.0](/filings/0000056978-26-000020.md) | [0.0](/filings/0000056978-26-000032.md) |
| Income tax | $m | [5.6 d](/filings/0000056978-25-000081.md) | [2.3](/filings/0000056978-25-000029.md) | [6.4](/filings/0000056978-25-000056.md) | [4.1](/filings/0000056978-25-000071.md) | [(2.0) d](/filings/0000056978-25-000081.md) | [11.3](/filings/0000056978-26-000012.md) | [5.4](/filings/0000056978-26-000020.md) | [3.2](/filings/0000056978-26-000032.md) | [0.3 d](/filings/0000056978-25-000081.md) | [5.7](/filings/0000056978-26-000012.md) | [7.4](/filings/0000056978-26-000020.md) | [15.3](/filings/0000056978-26-000032.md) |
| Net income | $m | [23.4 d](/filings/0000056978-25-000081.md) | [9.3](/filings/0000056978-25-000071.md) | [(103)](/filings/0000056978-25-000071.md) | [12.3](/filings/0000056978-25-000071.md) | [12.1 d](/filings/0000056978-25-000081.md) | [81.6](/filings/0000056978-26-000032.md) | [(84.5)](/filings/0000056978-26-000032.md) | [(3.3)](/filings/0000056978-26-000032.md) | [6.4 d](/filings/0000056978-25-000081.md) | [16.8](/filings/0000056978-26-000032.md) | [35.1](/filings/0000056978-26-000032.md) | [57.4](/filings/0000056978-26-000032.md) |
| Diluted EPS | $ per share | not reported | [0.16](/filings/0000056978-25-000029.md) | [(1.83)](/filings/0000056978-25-000056.md) | [0.22](/filings/0000056978-25-000071.md) | not reported | [1.51](/filings/0000056978-26-000012.md) | [(1.59)](/filings/0000056978-26-000020.md) | [(0.06)](/filings/0000056978-26-000032.md) | not reported | [0.32](/filings/0000056978-26-000012.md) | [0.66](/filings/0000056978-26-000020.md) | [1.07](/filings/0000056978-26-000032.md) |
| Basic EPS | $ per share | not reported | [0.16](/filings/0000056978-25-000029.md) | [(1.83)](/filings/0000056978-25-000056.md) | [0.22](/filings/0000056978-25-000071.md) | not reported | [1.52](/filings/0000056978-26-000012.md) | [(1.59)](/filings/0000056978-26-000020.md) | [(0.06)](/filings/0000056978-26-000032.md) | not reported | [0.32](/filings/0000056978-26-000012.md) | [0.67](/filings/0000056978-26-000020.md) | [1.10](/filings/0000056978-26-000032.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | FY2025 (2025-10-04) | Q1 FY2026 (2026-01-03) | Q2 FY2026 (2026-04-04) | Q3 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [529](/filings/0000056978-24-000148.md) | [425](/filings/0000056978-24-000034.md) | [360](/filings/0000056978-24-000064.md) | [367](/filings/0000056978-24-000099.md) | [227](/filings/0000056978-25-000081.md) | [278](/filings/0000056978-25-000029.md) | [287](/filings/0000056978-25-000056.md) | [246](/filings/0000056978-25-000071.md) | [216](/filings/0000056978-26-000032.md) | [282](/filings/0000056978-26-000012.md) | [338](/filings/0000056978-26-000020.md) | [369](/filings/0000056978-26-000032.md) |
| Current assets | $m | [1,189](/filings/0000056978-24-000148.md) | [1,178](/filings/0000056978-24-000034.md) | [1,050](/filings/0000056978-24-000064.md) | [1,013](/filings/0000056978-24-000099.md) | [995](/filings/0000056978-25-000081.md) | [1,014](/filings/0000056978-25-000029.md) | [948](/filings/0000056978-25-000056.md) | [930](/filings/0000056978-25-000071.md) | [902](/filings/0000056978-26-000032.md) | [914](/filings/0000056978-26-000012.md) | [982](/filings/0000056978-26-000020.md) | [1,105](/filings/0000056978-26-000032.md) |
| Total assets | $m | [1,500](/filings/0000056978-24-000148.md) | [1,487](/filings/0000056978-24-000034.md) | [1,299](/filings/0000056978-24-000064.md) | [1,257](/filings/0000056978-24-000099.md) | [1,240](/filings/0000056978-25-000081.md) | [1,251](/filings/0000056978-25-000029.md) | [1,145](/filings/0000056978-25-000056.md) | [1,125](/filings/0000056978-25-000071.md) | [1,104](/filings/0000056978-26-000032.md) | [1,115](/filings/0000056978-26-000012.md) | [1,186](/filings/0000056978-26-000020.md) | [1,319](/filings/0000056978-26-000032.md) |
| Current liabilities | $m | [182](/filings/0000056978-24-000148.md) | [181](/filings/0000056978-24-000034.md) | [166](/filings/0000056978-24-000064.md) | [166](/filings/0000056978-24-000099.md) | [184](/filings/0000056978-25-000081.md) | [169](/filings/0000056978-25-000029.md) | [183](/filings/0000056978-25-000056.md) | [188](/filings/0000056978-25-000071.md) | [188](/filings/0000056978-26-000032.md) | [197](/filings/0000056978-26-000012.md) | [234](/filings/0000056978-26-000020.md) | [321](/filings/0000056978-26-000032.md) |
| Total liabilities | $m | [325](/filings/0000056978-24-000148.md) | [325](/filings/0000056978-24-000034.md) | [287](/filings/0000056978-24-000064.md) | [284](/filings/0000056978-24-000099.md) | [296](/filings/0000056978-25-000081.md) | [279](/filings/0000056978-25-000029.md) | [281](/filings/0000056978-25-000056.md) | [287](/filings/0000056978-25-000071.md) | [283](/filings/0000056978-26-000032.md) | [290](/filings/0000056978-26-000012.md) | [328](/filings/0000056978-26-000020.md) | [407](/filings/0000056978-26-000032.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,175](/filings/0000056978-25-000081.md) | [1,161](/filings/0000056978-25-000071.md) | [1,012](/filings/0000056978-25-000071.md) | [974](/filings/0000056978-25-000071.md) | [944](/filings/0000056978-26-000032.md) | [973](/filings/0000056978-26-000032.md) | [864](/filings/0000056978-26-000032.md) | [838](/filings/0000056978-26-000032.md) | [821](/filings/0000056978-26-000032.md) | [825](/filings/0000056978-26-000032.md) | [858](/filings/0000056978-26-000032.md) | [912](/filings/0000056978-26-000032.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-10-04) | Q1 FY2026 (2026-01-03) | Q2 FY2026 (2026-04-04) | Q3 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [77.5 d](/filings/0000056978-25-000081.md) | [(7.3)](/filings/0000056978-25-000029.md) | [(20.1) d](/filings/0000056978-25-000056.md) | [26.9 d](/filings/0000056978-25-000071.md) | [31.6 d](/filings/0000056978-25-000081.md) | [18.9](/filings/0000056978-26-000012.md) | [79.9 d](/filings/0000056978-26-000020.md) | [6.2 d](/filings/0000056978-26-000032.md) | [8.6 d](/filings/0000056978-25-000081.md) | [(8.9)](/filings/0000056978-26-000012.md) | [10.3 d](/filings/0000056978-26-000020.md) | [45.2 d](/filings/0000056978-26-000032.md) |
| Capital expenditure | $m | [9.3 d](/filings/0000056978-25-000081.md) | [4.4](/filings/0000056978-25-000029.md) | [6.6 d](/filings/0000056978-25-000056.md) | [2.7 d](/filings/0000056978-25-000071.md) | [2.5 d](/filings/0000056978-25-000081.md) | [10.2](/filings/0000056978-26-000012.md) | [2.0 d](/filings/0000056978-26-000020.md) | [2.1 d](/filings/0000056978-26-000032.md) | [3.0 d](/filings/0000056978-25-000081.md) | [2.7](/filings/0000056978-26-000012.md) | [4.1 d](/filings/0000056978-26-000020.md) | [4.3 d](/filings/0000056978-26-000032.md) |
| Share repurchases | $m | [8.6 d](/filings/0000056978-25-000081.md) | [27.2](/filings/0000056978-25-000029.md) | [36.2 d](/filings/0000056978-25-000056.md) | [44.7 d](/filings/0000056978-25-000071.md) | [42.7 d](/filings/0000056978-25-000081.md) | [37.2](/filings/0000056978-26-000012.md) | [21.3 d](/filings/0000056978-26-000020.md) | [21.6 d](/filings/0000056978-26-000032.md) | [17.0 d](/filings/0000056978-25-000081.md) | [6.7](/filings/0000056978-26-000012.md) | [0.2 d](/filings/0000056978-26-000020.md) | [0.5 d](/filings/0000056978-26-000032.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-04-01) | Q3 FY2023 (2023-07-01) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q1 FY2026 (2026-01-03) | Q2 FY2026 (2026-04-04) | Q3 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [57.7](/filings/0000056978-24-000034.md) | [57.6](/filings/0000056978-24-000064.md) | [57.5](/filings/0000056978-24-000099.md) | [57.0](/filings/0000056978-25-000029.md) | [56.2](/filings/0000056978-25-000056.md) | [55.7](/filings/0000056978-25-000071.md) | [54.2](/filings/0000056978-26-000012.md) | [53.3](/filings/0000056978-26-000020.md) | [52.7](/filings/0000056978-26-000032.md) | [52.5](/filings/0000056978-26-000012.md) | [53.1](/filings/0000056978-26-000020.md) | [53.4](/filings/0000056978-26-000032.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 52,329,115 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0000056978-26-000032.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.